BioStock: Respiratorius’ US patent application reopens

After the initial rejection of Respiratorius’ patent application, the US Patent and Trademark Office’s Patent Trial and Appeal Board has now sided with the company. The decision means a reopening of the application regarding the oral formulation of VAL001. BioStock has contacted CEO Johan Drott to gain a better understanding of what this implies for the project.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/04/respiratorius-us-patent-application-reopens/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se